Skip to main content
Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ
Mol Cancer
2007,
6
:5
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 9 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
Suppression of non-small cell lung tumor development by the let-7 microRNA family.
Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T
Proc Natl Acad Sci U S A
2008 Mar 11,
105
:3903-8
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
2.
Dicer-dependent pathways regulate chondrocyte proliferation and differentiation.
Kobayashi T, Lu J, Cobb BS, Rodda SJ, McMahon AP, Schipani E, Merkenschlager M, Kronenberg HM
Proc Natl Acad Sci U S A
2008 Feb 12,
105
:1949-54
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
3.
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.
Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP
J Am Soc Nephrol
2008 Nov,
19
:2159-69
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
4.
microRNAs and death receptors.
Park SM, Peter ME
Cytokine Growth Factor Rev
2008 Jun-Aug,
19
:303-11
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
5.
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF
Am J Pathol
2009 Mar,
174
:736-45
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
6.
HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.
Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, Nakao M
Am J Pathol
2009 Mar,
174
:854-68
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
7.
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.
Peter ME
Cell Cycle
2009 Mar 15,
8
:843-52
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
8.
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.
Summer H, Li O, Bao Q, Zhan L, Peter S, Sathiyanathan P, Henderson D, Klonisch T, Goodman SD, Dröge P
Nucleic Acids Res
2009 Jul,
37
:4371-84
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
9.
[Epigenetic aspects in carcinomas of the head and neck]
Schmezer P, Plass C
HNO
2008 Jun,
56
:594-602
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
This article is also cited by
2 articles
in BioMed Central
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 9 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.